Press Releases

Filters
October 25, 2016

Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450

Read more
October 20, 2016

Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy

Read more
October 11, 2016

Coorpacademy raises 10 million euros and achieves one of the most important fundraisings in the European EdTech sector

Read more
October 7, 2016

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2016 JCA-Mauvernay Award

Read more
August 30, 2016

Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests

Read more
July 13, 2016

Debiopharm acquires a majority holding in the Canadian start-up GenePOC

Read more
July 11, 2016

Grand succès du Challenge Debiopharm Inartis

Read more
June 7, 2016

Debiopharm International SA initiates clinical phase II study evaluating Debio 1143 in Ovarian Cancer

Read more
June 2, 2016

FDA grants Orphan Drug Designation to Debiopharm International SA’s IAP inhibitor Debio 1143 in the treatment of ovarian cancer

Read more